Literature DB >> 8894244

Management of resistant depression.

L Warneke1.   

Abstract

Treatment-resistant depression is a relative concept. It has been formally defined as a mood disorder that fails to respond to three adequate trials of antidepressants. However, treatment resistance is relative to the expertise and knowledge of the treating physician and the availability of resources, such as electroconvulsive therapy. Only about 7% of patients show absolute treatment resistance, and even they can be helped.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8894244      PMCID： PMC2146982     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  25 in total

1.  Adrenal function in asthmatic children treated with inhaled budesonide.

Authors:  H Bisgaard; S Pedersen; M Damkjaer Nielsen; O Osterballe
Journal:  Acta Paediatr Scand       Date:  1991-02

Review 2.  Psychosurgery for resistant depression: progress and problems.

Authors:  P Bridges
Journal:  Int Clin Psychopharmacol       Date:  1991-07       Impact factor: 1.659

3.  Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.

Authors:  E Frank; D J Kupfer; J M Perel; C Cornes; A G Mallinger; M E Thase; A B McEachran; V J Grochocinski
Journal:  J Affect Disord       Date:  1993-03       Impact factor: 4.839

4.  Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients.

Authors:  M J Filteau; Y D Lapierre; D Bakish; A Blanchard
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

5.  d-Amphetamine versus methylphenidate effects in depressed inpatients.

Authors:  K Y Little
Journal:  J Clin Psychiatry       Date:  1993-09       Impact factor: 4.384

Review 6.  Management of chronic asthma.

Authors:  D A Stempel; S J Szefler
Journal:  Pediatr Clin North Am       Date:  1992-12       Impact factor: 3.278

Review 7.  Antidepressant maintenance medications: when to discontinue and how to stop.

Authors:  J F Greden
Journal:  J Clin Psychiatry       Date:  1993-08       Impact factor: 4.384

8.  Importance of the inhalation device on the effect of budesonide.

Authors:  L Agertoft; S Pedersen
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

9.  Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

Authors:  M Fava; J F Rosenbaum; P J McGrath; J W Stewart; J D Amsterdam; F M Quitkin
Journal:  Am J Psychiatry       Date:  1994-09       Impact factor: 18.112

10.  Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma.

Authors:  P J Merkus; E E van Essen-Zandvliet; E J Duiverman; H C van Houwelingen; K F Kerrebijn; P H Quanjer
Journal:  Pediatrics       Date:  1993-06       Impact factor: 7.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.